Dr. Ledbetter is an internationally recognized expert in Genomics and Precision Medicine, having focused his early research efforts on discovering the genetic causes of childhood neurodevelopmental disorders such as autism, and the translation of new genomics technologies into clinically useful genetic tests for early diagnosis and intervention. His current research interests include leveraging longitudinal electronic health information with large-scale DNA sequencing to determine the clinical utility and cost-effectiveness of precision medicine approaches in real-world health system settings. He served as Executive Vice President and Founding Chief Scientific Officer at Geisinger for ten years (2010-2020), leading their ground-breaking genomics program-the first in the world to return medically actionable results to patient-participants. He held academic and leadership positions at Emory University, the University of Chicago, and Baylor College of Medicine, and is currently Professor at the University of Florida. He is a graduate of Tulane University and earned his Ph.D. at the University of Texas-Austin.
William Oh, Mount Sinai